You searched for "OCT "
World Clinics in Ophthalmology Series: Innovations in Primary Open Angle Glaucoma
1 April 2014
| Subhanjan Mukherji
|
EYE - Glaucoma, EYE - General, EYE - Paediatrics, EYE - Strabismus, EYE - Neuro-ophthalmology
This two volume publication about current innovations in primary open angle glaucoma has persevered to come out with a comprehensive review of the latest publications in the world of glaucoma. The list of contributors includes clinicians from the field of...
Intravitreal afibercept and ranibizumab for PCV
1 August 2016
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...
Glaucoma UK announces £100,000 Health and Social Care Professionals Award for 2024
Glaucoma UK is pleased to announce that applications for its Health and Social Care Professionals Research Award are now open.Moorfields: Joint Ocular Oncology and Vitreo Retinal Symposium for Nurses and Ophthalmic Health Care Professionals
15 November 2025
Following the success in 2024 of our first Joint Ocular Oncology and Vitreo Retinal Symposium for Nurses and Ophthalmic Health Care Professionals, we are delighted to announce that the symposium will take place again on 15 November 2025. This unique...
Dramatic myopic shift due to epithelial basement membrane dystrophy
3 October 2024
| Annes Ahmeidat, Blazej Staniszewski, James Welch
|
EYE - Cornea
Epithelial basement membrane dystrophy (EBMD), also known as map-dot-fingerprint dystrophy, is a common anterior corneal disorder affecting approximately 2% of the population [1]. It is characterised by the abnormal maintenance of the basement membrane, resulting in protrusions into the epithelium....
Transferring imaging from primary to secondary care (part 1)
5 August 2020
| David Haider
|
EYE - General
Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. For...
Sclerochoroidal calcification masquerading as ocular malignancy
Case 1 A 68-year-old Caucasian gentleman was urgently referred to eye casualty by his optometrist after seeing an unusual incidental finding of protruding lesions from the retina, suspecting choroidal melanoma. He was asymptomatic and this was his first eye test...Visual Fields via the Visual Pathway (Second Edition)
1 April 2017
| Fiona Rowe (Prof)
|
EYE - Glaucoma
This book is a very well-written and comprehensive text on visual field assessment and interpretation. It includes a large number of illustrations which are of a high quality and make it a good reading experience. The first section of the...
Intravitreal triamcinolone for uveitic macular oedema
1 June 2016
| Saruban Pasu
|
EYE - Vitreo-Retinal
This paper from South Korea reports on a prospective, double blind, randomised clinical study designed to evaluate the additional benefit of intravitreal triamcinolone (TA) administration for noninfectious uveitic macular oedema as an adjunct therapy to systemic anti-inflammatory treatment. Patients were...
Subfoveal choroidal thickness and PCV
1 April 2018
| Saruban Pasu
|
EYE - Vitreo-Retinal
This report studies the prognostic factors for visual improvement and the need for additional treatments at one year after the initial combination therapy of intravitreal ranibizumab injection or intravitreal aflibercept injection followed by PDT in eyes with PCV. Fifty-six eyes...
Choroidal and RNFL thickness in patients with OSAS
1 August 2015
| Anjali Gupta
|
EYE - Vitreo-Retinal
In obstructive sleep apnoea syndrome (OSAS), hypoxia secondary to repetitive apnoeic episodes leads to blood pressure variations and haemodynamic changes. There is also intermittent activation of the sympathetic system when the patient is aroused from sleep during apnoeic episodes. OSAS...
Outcomes of ‘treat and extend’ for neovascular AMD
1 August 2015
| Brian Ang
|
EYE - Vitreo-Retinal
The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...